[{"edinetCode":"E00945","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":3290.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":157613000.0,"sharesOwendPercent":0.2674,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":21.9,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2017\/6\/30","stockCode":4528,"accountingYear":"第69期(自　2016年４月１日　至　2017年３月31日)","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0},{"edinetCode":"E00945","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":3480.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":170669000.0,"sharesOwendPercent":0.3319,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":34.0,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2018\/6\/25","stockCode":4528,"accountingYear":"第70期(自　2017年４月１日　至　2018年３月31日)","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0},{"edinetCode":"E00945","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":3555.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":168598000.0,"sharesOwendPercent":0.3278,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":655056000000.0,"currentAssets":194617000000.0,"fixedAsset":null,"tangibleFixedAssets":108870000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":92321000000.0,"currentLiabilities":83150000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":17358000000.0,"capitalSurplus":17202000000.0,"accumulatedEarnings":499088000000.0,"treasuryStock":-38151000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":83829000000.0,"grossProfit":null,"sgaExpenses":70033000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":21.6,"roe":null,"cashFlowFromOperatingActivities":66774000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-49763000000.0,"cashFlowFromFinancialActivities":-22279000000.0,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2019\/6\/21","stockCode":4528,"accountingYear":"第71期(自　2018年４月１日　至　2019年３月31日)","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0},{"edinetCode":"E00945","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":641060000000.0,"currentAssets":178110000000.0,"fixedAsset":null,"tangibleFixedAssets":114922000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":86356000000.0,"currentLiabilities":72399000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":17358000000.0,"capitalSurplus":17209000000.0,"accumulatedEarnings":504148000000.0,"treasuryStock":-48153000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":20730000000.0,"grossProfit":null,"sgaExpenses":16573000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":6337000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-5531000000.0,"cashFlowFromFinancialActivities":-20980000000.0,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/7","stockCode":4528,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0},{"edinetCode":"E00945","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":166962000.0,"sharesOwendPercent":0.3344,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":642125000000.0,"currentAssets":209933000000.0,"fixedAsset":null,"tangibleFixedAssets":115326000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":87176000000.0,"currentLiabilities":73111000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":17358000000.0,"capitalSurplus":17215000000.0,"accumulatedEarnings":520797000000.0,"treasuryStock":-67735000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":41668000000.0,"grossProfit":null,"sgaExpenses":33734000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":34875000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":2681000000.0,"cashFlowFromFinancialActivities":-42218000000.0,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2019\/11\/7","stockCode":4528,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0},{"edinetCode":"E00945","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":659217000000.0,"currentAssets":225431000000.0,"fixedAsset":null,"tangibleFixedAssets":114786000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":86195000000.0,"currentLiabilities":72452000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":17358000000.0,"capitalSurplus":17222000000.0,"accumulatedEarnings":511015000000.0,"treasuryStock":-44736000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":61555000000.0,"grossProfit":null,"sgaExpenses":50938000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":50178000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":10349000000.0,"cashFlowFromFinancialActivities":-53391000000.0,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/7","stockCode":4528,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0},{"edinetCode":"E00945","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":3560.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":171484000.0,"sharesOwendPercent":0.3435,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":673444000000.0,"currentAssets":225222000000.0,"fixedAsset":null,"tangibleFixedAssets":114628000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":105422000000.0,"currentLiabilities":91329000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":17358000000.0,"capitalSurplus":17229000000.0,"accumulatedEarnings":524605000000.0,"treasuryStock":-44737000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":79063000000.0,"grossProfit":null,"sgaExpenses":67679000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":21.0,"roe":null,"cashFlowFromOperatingActivities":74157000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-10234000000.0,"cashFlowFromFinancialActivities":-54721000000.0,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2020\/6\/19","stockCode":4528,"accountingYear":"第72期(自　2019年４月１日　至　2020年３月31日)","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0},{"edinetCode":"E00945","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":678509000000.0,"currentAssets":224636000000.0,"fixedAsset":null,"tangibleFixedAssets":112967000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":89573000000.0,"currentLiabilities":76231000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":17358000000.0,"capitalSurplus":17198000000.0,"accumulatedEarnings":535154000000.0,"treasuryStock":-44701000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":20563000000.0,"grossProfit":null,"sgaExpenses":14199000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":10412000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-3776000000.0,"cashFlowFromFinancialActivities":-10803000000.0,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/6","stockCode":4528,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0},{"edinetCode":"E00945","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":177090000.0,"sharesOwendPercent":0.3547,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":706795000000.0,"currentAssets":226772000000.0,"fixedAsset":null,"tangibleFixedAssets":113813000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":96197000000.0,"currentLiabilities":81557000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":17358000000.0,"capitalSurplus":17209000000.0,"accumulatedEarnings":554504000000.0,"treasuryStock":-44702000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":41760000000.0,"grossProfit":null,"sgaExpenses":29817000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":31314000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-4033000000.0,"cashFlowFromFinancialActivities":-12488000000.0,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2020\/11\/6","stockCode":4528,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0},{"edinetCode":"E00945","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":718991000000.0,"currentAssets":239756000000.0,"fixedAsset":null,"tangibleFixedAssets":114043000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":90807000000.0,"currentLiabilities":76790000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":17358000000.0,"capitalSurplus":17220000000.0,"accumulatedEarnings":571592000000.0,"treasuryStock":-44704000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":66151000000.0,"grossProfit":null,"sgaExpenses":48216000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":48032000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-5980000000.0,"cashFlowFromFinancialActivities":-23626000000.0,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/12","stockCode":4528,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0},{"edinetCode":"E00945","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":3607.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":176951000.0,"sharesOwendPercent":0.3544,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":746842000000.0,"currentAssets":247642000000.0,"fixedAsset":null,"tangibleFixedAssets":113866000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":105685000000.0,"currentLiabilities":93733000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":17358000000.0,"capitalSurplus":17231000000.0,"accumulatedEarnings":583363000000.0,"treasuryStock":-44705000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":85573000000.0,"grossProfit":null,"sgaExpenses":69230000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":19.1,"roe":null,"cashFlowFromOperatingActivities":73977000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-57586000000.0,"cashFlowFromFinancialActivities":-24754000000.0,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2021\/6\/18","stockCode":4528,"accountingYear":"第73期(自　2020年４月１日　至　2021年３月31日)","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0},{"edinetCode":"E00945","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":742873000000.0,"currentAssets":243671000000.0,"fixedAsset":null,"tangibleFixedAssets":113190000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":92740000000.0,"currentLiabilities":80870000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":17358000000.0,"capitalSurplus":17211000000.0,"accumulatedEarnings":593921000000.0,"treasuryStock":-44675000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":22799000000.0,"grossProfit":null,"sgaExpenses":18955000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":6756000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-5121000000.0,"cashFlowFromFinancialActivities":-13276000000.0,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/6","stockCode":4528,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0},{"edinetCode":"E00945","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":200552000.0,"sharesOwendPercent":0.4017,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":772900000000.0,"currentAssets":276115000000.0,"fixedAsset":null,"tangibleFixedAssets":112050000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":93202000000.0,"currentLiabilities":81217000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":17358000000.0,"capitalSurplus":17221000000.0,"accumulatedEarnings":617669000000.0,"treasuryStock":-44676000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":45567000000.0,"grossProfit":null,"sgaExpenses":37656000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":40369000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-5385000000.0,"cashFlowFromFinancialActivities":-14968000000.0,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2021\/11\/5","stockCode":4528,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0},{"edinetCode":"E00945","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":740057000000.0,"currentAssets":268690000000.0,"fixedAsset":null,"tangibleFixedAssets":112515000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":73733000000.0,"currentLiabilities":61898000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":17358000000.0,"capitalSurplus":17231000000.0,"accumulatedEarnings":628108000000.0,"treasuryStock":-60134000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":70634000000.0,"grossProfit":null,"sgaExpenses":57488000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":27398000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":18056000000.0,"cashFlowFromFinancialActivities":-44234000000.0,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/4","stockCode":4528,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00945","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":17358,"settlementDate":"2022\/3\/31","submitterName":"小野薬品工業株式会社","submitterNameEnglish":"ONO PHARMACEUTICAL CO., LTD.","submitterNameKana":"オノヤクヒンコウギョウカブシキガイシャ","location":"大阪市中央区道修町二丁目１番５号","industory":"医薬品","corporateNumber":7120000000000.0}]